Westminster, CA, United States of America

Max D Lechtman


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1990-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Max D Lechtman: Innovator in Extracorporeal Blood Treatment

Introduction

Max D Lechtman is a notable inventor based in Westminster, CA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of blood-borne infections. With a total of 2 patents, his work focuses on innovative methods for extracorporeal blood treatment.

Latest Patents

Lechtman's latest patents include a "Method and apparatus for extracorporeal blood treatment" and a "Method for extracorporeal blood shear treatment." Both patents disclose a multimodal approach to treating infections, such as those caused by the Human Immunodeficiency Virus (HIV). The methods involve hyperthermic, mechanical shear inducing, and irradiation treatment modalities. These modalities can be executed separately, in any order, or simultaneously. The irradiation treatment includes subjecting blood to ultraviolet, x-ray, or laser radiation. Prior to blood withdrawal, a chemical agent like heparin may be administered to facilitate lymphocyte migration from the lymphatic system into the circulatory system. After extracting the desired volume of blood, volume extenders can be mixed with the blood to adjust the extracorporeal blood volume as needed. Once the treatment is complete, the treated blood is returned to the patient.

Career Highlights

Max D Lechtman is associated with American Immuno Tech, LLC, where he continues to develop innovative solutions in the medical field. His work has the potential to significantly impact the treatment of blood-borne infections, improving patient outcomes.

Collaborations

Lechtman has collaborated with notable professionals in his field, including Alan A Davidner and Henry V Roohk. Their combined expertise contributes to the advancement of medical technologies.

Conclusion

Max D Lechtman's contributions to extracorporeal blood treatment exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving medical treatments and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…